Lori Koch
Director of Finance/CFO at DUPONT DE NEMOURS, INC.
Net worth: 8 M $ as of 2024-03-30
Profile
Presently, Lori D. Koch occupies the position of Chief Financial Officer & Executive Vice President at DuPont de Nemours, Inc. and Director, Chief Financial Officer & Executive VP at Nutrition & Biosciences, Inc. (a subsidiary of DuPont de Nemours, Inc.). Ms. Koch is also on the board of Aceto Corp. Ms. Koch received a graduate degree and an undergraduate degree from Babson College and an undergraduate degree from The Pennsylvania State University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
DUPONT DE NEMOURS, INC.
0.02% | 2024-03-01 | 100,219 ( 0.02% ) | 8 M $ | 2024-03-30 |
Lori Koch active positions
Companies | Position | Start |
---|---|---|
DUPONT DE NEMOURS, INC. | Director of Finance/CFO | 2020-02-16 |
ACETO CORPORATION | Director/Board Member | 2019-11-30 |
Nutrition & Biosciences, Inc.
Nutrition & Biosciences, Inc. Chemicals: Major DiversifiedProcess Industries Nutrition & Biosciences, Inc. manufactures and distributes food & beverages, dietary supplements, and pharmaceutical products. The company is headquartered in Wilmington, DE. | Director of Finance/CFO | - |
Former positions of Lori Koch
Companies | Position | End |
---|---|---|
E I DU PONT DE NEMOURS AND CO | Director of Finance/CFO | - |
Training of Lori Koch
Babson College | Graduate Degree |
The Pennsylvania State University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
DUPONT DE NEMOURS, INC. | Process Industries |
Private companies | 3 |
---|---|
Actylis Corp.
Actylis Corp. Pharmaceuticals: GenericHealth Technology Actylis Corp. engages in the development, marketing, sale, and distribution of chemical compounds used in the pharmaceutical, nutraceutical, agricultural, coatings, and industrial chemical industries. It operates through the following segments: Human Health, Pharmaceutical Ingredients, and Performance Chemicals. The Human Health segment develops and sells finished dosage form generic drugs and nutraceutical products. The Pharmaceutical Ingredients segment supplies active pharmaceutical ingredients and pharmaceutical intermediates. The Performance Chemicals segment comprises of specialty chemicals and agricultural protection products. The company was founded in 1947 and is headquartered in Port Washington, NY. | Health Technology |
EIDP, Inc.
EIDP, Inc. Chemicals: AgriculturalProcess Industries EIDP, Inc. engages in the provision of science-based products and services. It operates through the Seed and Crop Protection segments. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms around the world. The Crop Protection segment serves the global agricultural input industry with products that protect against weeds, insects and other pests, and disease, and that improve overall crop health both above and below ground via nitrogen management and seed-applied technologies. The company was founded by Eleuthere Irenee du Pont in 1802 and is headquartered in Indianapolis, IN. | Process Industries |
Nutrition & Biosciences, Inc.
Nutrition & Biosciences, Inc. Chemicals: Major DiversifiedProcess Industries Nutrition & Biosciences, Inc. manufactures and distributes food & beverages, dietary supplements, and pharmaceutical products. The company is headquartered in Wilmington, DE. | Process Industries |
- Stock Market
- Insiders
- Lori Koch